Uijeongbu St. Mary's Hospital Earns 'Grade 1' in Tuberculosis and COPD Quality Assessments

Both assessments scored above the overall average
Rates for key tuberculosis tests reached 100%

The Catholic University of Korea Uijeongbu St. Mary's Hospital, headed by Director Lee Tae-gyu, announced on November 3 that it received Grade 1 in both the 2025 tuberculosis and chronic obstructive pulmonary disease quality assessments conducted by the Health Insurance Review & Assessment Service.

A view of Uijeongbu St. Mary's Hospital. Courtesy of Uijeongbu St. Mary's Hospital.

In the tuberculosis assessment, the hospital scored 97.4 points, above the overall average of 95.7. Its rates for tuberculosis bacteria confirmation tests, conventional drug susceptibility tests, and rapid drug susceptibility tests were all 100%.

In the chronic obstructive pulmonary disease assessment, the hospital scored 91.2 points, 19.3 points above the overall average of 71.9. The pulmonary function test rate was 90.1%, and the percentage of patients prescribed inhaled bronchodilators was 99.5%.

Joo Hyunsu, a professor of pulmonology, said, "For respiratory diseases, it is important not only to provide accurate diagnoses and appropriate treatment, but also to help patients continue their treatment consistently. As we approach the 70th anniversary of the hospital's opening, we will continue to strengthen our expertise in respiratory disease care so that local residents can receive trusted treatment close to home."

This content was produced with the assistance of AI translation services.